This metabolic slowdown explains why people with untreated or undertreated hypothyroidism often experience rapid weight gain despite eating the same amount as before diagnosis
Animal Evidence (Moderate) Uno and Kubo (1992) evaluated peptide-copper complexes in C3H mice a standard model for hair growth research
Oral semaglutide represents an additional option for treating people with type 2 diabetes in primary care, with the potential to expand the numbers of patients benefiting from GLP-1RAs beyond that currently seen with injectable formulations
The SURMOUNT trial program proved it with hard data, showing tirzepatide weight loss results that exceeded anything achieved by GLP-1-only medications
Subsequently, in 1986, the pioneering work of Holst, Habener, Mojsov, and Drucker led to the discovery of glucagon-like peptide-1 (GLP-1), an incretin with approximately 50% homology to glucagon
Bone biomarker response to walking under different thermal conditions in older adults